Bavarian Nordic A/S (BVNRY)
11.04
-0.12
(-1.03%)
USD |
OTCM |
Sep 25, 16:00
Bavarian Nordic Net Income (TTM) : 241.04M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 241.04M |
| March 31, 2026 | 182.28M |
| December 31, 2025 | 210.49M |
| September 30, 2025 | 367.29M |
| June 30, 2025 | 206.55M |
| March 31, 2025 | 189.16M |
| December 31, 2024 | 141.64M |
| September 30, 2024 | 161.38M |
| June 30, 2024 | 101.28M |
| March 31, 2024 | 142.21M |
| December 31, 2023 | 213.12M |
| September 30, 2023 | 103.66M |
| June 30, 2023 | 155.02M |
| March 31, 2023 | 42.48M |
| December 31, 2022 | -52.77M |
| September 30, 2022 | -89.00M |
| June 30, 2022 | -103.55M |
| March 31, 2022 | -93.98M |
| December 31, 2021 | -74.17M |
| September 30, 2021 | -118.47M |
| June 30, 2021 | -101.43M |
| March 31, 2021 | -60.64M |
| December 31, 2020 | 36.43M |
| September 30, 2020 | 89.64M |
| June 30, 2020 | 70.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 38.94M |
| December 31, 2019 | -52.09M |
| September 30, 2019 | -60.80M |
| June 30, 2019 | -41.07M |
| March 31, 2019 | -43.27M |
| December 31, 2018 | -58.22M |
| September 30, 2018 | -71.92M |
| June 30, 2018 | -25.43M |
| March 31, 2018 | -1.020M |
| December 31, 2017 | 28.22M |
| September 30, 2017 | 70.07M |
| June 30, 2017 | 33.31M |
| March 31, 2017 | 22.54M |
| December 31, 2016 | 4.378M |
| September 30, 2016 | -7.932M |
| June 30, 2016 | -29.99M |
| March 31, 2016 | -16.99M |
| December 31, 2015 | 8.885M |
| September 30, 2015 | 24.98M |
| June 30, 2015 | 29.12M |
| March 31, 2015 | 9.949M |
| December 31, 2014 | 3.318M |
| September 30, 2014 | -18.01M |
| June 30, 2014 | -11.35M |
| March 31, 2014 | -2.190M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Evaxion AS | -8.683M |
| Genmab A/S | 785.93M |
| Ascendis Pharma A/S | 866.59M |
| Zealand Pharma A/S | 425.33M |
| Agenus, Inc. | 91.94M |